Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review

No abstract is available for this paper.

• Publication year

  2010

• Venue

  BJOG: an International Journal of Obstetrics and Gynaecology

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1471-0528.2010.02657.xPMID 20618318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is it the time?

  2011cited by this paper
• Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme

  2009cited by this paper
• The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia - Where does it stand?

  2009cited by this paper
• Is it time to implement HPA-1 screening in pregnancy?

  2009cited by this paper
• Prevalence and Evolution of Intracranial Hemorrhage in Asymptomatic Term Infants

  2008cited by this paper
• Fetal and neonatal alloimmune thrombocytopenia.

  2008cited by this paper
• Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

  2008cited by this paper
• Fetal thrombocytopenia.

  2008cited by this paper
• Immunogenicity of and immune response to the human platelet antigen Zwa is strongly associated with HLA-B8 and DR3.

  2008cited by this paper
• A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

  2008cited by this paper
• Maternal human platelet antigen‐1a antibody level correlates with the platelet count in the newborns: a retrospective study

  2007cited by this paper
• HPA‐1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopenia

  2007cited by this paper
• Intracranial hemorrhage in asymptomatic neonates: prevalence on MR images and relationship to obstetric and neonatal risk factors.

  2007cited by this paper
• Monoclonal platelet antigen capture assays (MAIPA) and reagents: a statement

  2007cited by this paper
• A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.

  2007cited by this paper
• Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective

  2007cited by this paper
• Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia?

  2006cited by this paper
• Parallel Randomized Trials of Risk-Based Therapy for Fetal Alloimmune Thrombocytopenia

  2006cited by this paper
• Prospective epidemiologic study of the outcome and cost‐effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti‐HPA‐1a

  2005cited by this paper
• Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?

  2003cited by this paper
• Antenatal screening of unselected pregnant women for HPA‐1a antigen, antibody and alloimmune thrombocytopenia

  2003cited by this paper
• Antenatal screening for human platelet antigen‐1a: results of a prospective study at a large maternity hospital in Ireland

  2003cited by this paper
• European collaborative study of the antenatal management of feto‐maternal alloimmune thrombocytopenia

  2003cited by this paper
• Antenatal Screening for Fetomaternal Alloimmune Thrombocytopenia: Should we be doing it?

  2002cited by this paper
• Fetomaternal alloimmune thrombocytopenia: a literature review and statistical analysis

  2001cited by this paper
• Is it Time

  2001cited by this paper
• Antenatal screening for fetomaternal alloimmune thrombocytopenia: an evaluation using the criteria of the uk national screening committee

  2000cited by this paper
• Neonatal alloimmune thrombocytopenia due to anti‐HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn

  2000cited by this paper
• Feto‐maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids — more questions than answers

  1998cited by this paper
• The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening.

  1998cited by this paper
• Fetal alloimmune thrombocytopenia.

  1997cited by this paper
• Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group.

  1996cited by this paper
• Alloimmune Thrombocytopenia of the Newborn: Neurodevelopmental Sequelae

  1996cited by this paper
• Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study

  1995cited by this paper
• Flow cytometric phenotyping of platelet HPA-1a antigen: donor screening for a case of neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies

  1995cited by this paper
• Fetal thrombocytopenia and its relation to maternal thrombocytopenia.

  1993cited by this paper
• HLA-DRw52a is involved in alloimmunization against PL-A1 antigen.

  1990cited by this paper
• Alloimmunization to the PIA1 platelet antigen: results of a prospective study

  1990cited by this paper
• Screening for neonatal alloimmune thrombocytopenia: an economic perspective.

  1988cited by this paper
• Allo-immune thrombocytopenias, definition of a group at risk; a prospective study.

  1988cited by this paper

• Fetal and neonatal alloimmune thrombocytopenia (FNAIT): From reactive transfusion to proactive prevention.

  2026cites this paper
• The Ethics of Clinical Research on Diseases of the Fetus and Newborn: Balancing Benefit–Risk, Autonomy, and Maternal–Fetal Interests

  2025cites this paper
• Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

  2025cites this paper
• Routine Cord Blood Platelet Counts and Potential for Severe Neonatal Alloimmune Thrombocytopaenia (NAIT): A Cohort Study of 12 Yr. Experience at Middlemore Hospital, New Zealand

  2025cites this paper
• From concept to practice: Screening for fetal and neonatal alloimmune thrombocytopenia (FNAIT).

  2025cites this paper
• Clinical management in FNAIT - navigating a complicated landscape.

  2025cites this paper
• Effectiveness of antenatal intravenous immunoglobulin treatment in recurrent fetal and neonatal alloimmune thrombocytopenia

  2025cites this paper
• Diagnosis and Management of Fetal and Neonatal Alloimmune Thrombocytopenia: An Update 2025

  2025cites this paper
• Fetale und neonatale Alloimmunthrombozytopenie

  2025cites this paper
• Fetal–neonatal alloimmune thrombocytopenia: Mothers are affected too

  2025cites this paper
• A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention

  2024cites this paper
• Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: A cost–utility analysis

  2024influential citation
• Informing pregnancy dose via target‐mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody

  2024cites this paper
• Placenta-associated biomarkers and pregnancy outcome in HPA-1a alloimmunization: A prospective cohort study.

  2024cites this paper
• Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions

  2024cites this paper
• Frequency of human platelet antigens (HPA) in the Greek population as deduced from the first registry of HPA‐typed blood donors

  2024influential citation
• In vitro Generated Megakaryocytes for the Detection of Human Platelet Antigen-Specific Alloantibodies

  2024cites this paper
• Fetal and neonatal alloimmune thrombocytopenia: No evidence of systemic inflammation as a modulator of disease severity. Could placental inflammation be key?

  2023cites this paper
• What's with the boys? Lower birth weight in boys from HPA-1a alloimmunized pregnancies - New insights from a large prospective screening study in Poland.

  2023cites this paper
• Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study.

  2023cites this paper
• Fetal and neonatal alloimmune thrombocytopenia: A rare case report of prenatal treatment

  2023cites this paper
• Children Newly Diagnosed with Fetal and Neonatal Alloimmune Thrombocytopenia: Neurodevelopmental Outcome at School Age.

  2023cites this paper
• Fetal neonatal alloimmune thrombocytopenia treatment with intravenous immunoglobulin: a challenge in pregnancy management and infection assessment ‒ case report

  2022cites this paper
• Afucosylated IgG responses in humans – structural clues to the regulation of humoral immunity

  2022influential citation
• Approach to Neonatal Alloimmune Thrombocytopenia: The Perspective from a Transfusion Medicine Service

  2022cites this paper
• Noninvasive Prenatal Testing in Immunohematology—Clinical, Technical and Ethical Considerations

  2022cites this paper
• Targeting neonatal Fc receptor: potential clinical applications in pregnancy

  2022cites this paper
• Next Generation Sequencing of Human Platelet Antigens for Routine Clinical Investigations and Donor Screening.

  2022cites this paper
• Clinical characteristics of human platelet antigen (HPA)‐1a and HPA‐5b alloimmunised pregnancies and the association between platelet HPA‐5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia

  2021cites this paper
• Fetale und neonatale Alloimmunthrombozytopenie, Teil 1

  2021influential citation
• Maternal Thrombocytopenia: Obstetricians Dilemma, to Act or Not?

  2021cites this paper
• A case report of prenatal diagnosis of fetal alloimmune thrombocytopenia

  2021cites this paper
• To find the correlation of the clinical findings with Hematological findings of bleeding disorders subjects

  2021cites this paper
• Down syndrome with neonatal alloimmune thrombocytopenia due to anti-HLA A31 and B61 antibodies

  2021cites this paper
• HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk

  2020cites this paper
• Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events

  2020cites this paper
• Neonatal Immune Incompatibilities between Newborn and Mother

  2020cites this paper
• The prevalence of HPA‐1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR‐DQ haplotypes

  2020cites this paper
• Preimplantation genetic testing for a monogenic disorder can prevent live births affected by fetal and neonatal alloimmune thrombocytopenia

  2020cites this paper
• A new efficient tool for non‐invasive diagnosis of fetomaternal platelet antigen incompatibility

  2020cites this paper
• Fetal hydrops – a review and a clinical approach to identifying the cause

  2020cites this paper
• Immune-Mediated Cytopenia in the Pediatric Setting

  2020cites this paper
• Alloantibodies and Platelets

  2020cites this paper
• Diagnostic et prise en charge d´une thrombopénie néonatale sévère par allo-immunisation materno-fœtale: rapport d´un cas et revue de la littérature

  2020influential citation
• Fetal Platelet Disorders

  2020cites this paper
• Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.

  2020cites this paper
• Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome.

  2020cites this paper
• Prospects for risk stratification of anti-HPA-1a alloimmunized pregnant women.

  2019cites this paper
• Risk of HPA‐1a–immunization in HPA‐1a–negative women after giving birth to an HPA‐1a–positive child

  2019influential citation
• Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach

  2019cites this paper
• ACOG Practice Bulletin No. 207: Thrombocytopenia in Pregnancy.

  2019cites this paper
• Fetal and Neonatal Alloimmune Thrombocytopenia

  2019cites this paper
• HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.

  2019cites this paper
• A cross cultural examination of the experiences of parents of children when being diagnosed with Foetal and Neonatal Alloimmune Thrombocytopenia

  2019cites this paper
• Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT)

  2019cites this paper
• Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopenia

  2019cites this paper
• High dose carfilzomib proteasome inhibition induces anemia by oxidative hemolysis: A case series of 8 patients from a single centre

  2019cites this paper
• Fast and low‐cost direct ELISA for high‐throughput serological HPA‐1a typing

  2019cites this paper
• Application of flow cytometry in transfusion medicine

  2019cites this paper
• Fetal and Neonatal Alloimmune Thrombocytopenia: Clinical Disease and Management

  2019cites this paper
• Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia.

  2019cites this paper
• Foetal and neonatal alloimmune thrombocytopenia.

  2019cites this paper
• Thrombocytopenia in Pregnancy

  2019cites this paper
• Screening for fetal and neonatal alloimmune thrombocytopenia: is it possible and what are the potential outcomes?

  2018cites this paper
• Maternal HPA‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review

  2018cites this paper
• Perinatal Outcome and Long-Term Neurodevelopment after Intracranial Haemorrhage due to Fetal and Neonatal Alloimmune Thrombocytopenia

  2018cites this paper
• Marked thrombocytopenia in a neonate is associated with anti‐HPA‐5b, anti‐HLA‐A31, and anti‐HLA‐B55 antibodies

  2018cites this paper
• Flow cytometry in transfusion medicine: an overview

  2018cites this paper
• Intracranial hemorrhages in neonates born from 32 weeks of gestation—low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register‐based study

  2018cites this paper
• New elegant methods for maternal and fetal HPA‐1a typing

  2018cites this paper
• Bleeding or no bleeding? Anti‐endothelial alphaVbeta3 antibodies as a major cause of intracranial haemorrhage in fetal–neonatal alloimmune thrombocytopenia

  2018cites this paper
• Noninvasive prenatal diagnosis by cell‐free DNA screening for fetomaternal HPA‐1a platelet incompatibility

  2018cites this paper
• Maternal Anti-HLA Class I Antibodies in Connection with Pregnancy and Neonatal Thrombocytopenia – a Cause for Concern? Clinical Characteristics and Antibody Analysis of Retrospective and Prospective Populations

  2017influential citation
• Maternal anti-HLA class I antibodies are associated with reduced birth weight in thrombocytopenic neonates

  2017cites this paper
• Prevention of alloimmunization during pregnancy by prednisone and immunoglobulin G—What is the evidence?

  2017cites this paper
• Fetal and neonatal alloimmune thrombocytopenia : towards implementation of screening in pregnancy

  2017cites this paper
• Women ’ s attitude towards routine HPA-screening in pregnancy Running headline : Attitude towards HPA-screening in Pregnancy

  2017cites this paper
• Alloimmunologiczna małopłytkowość noworodków

  2017cites this paper
• Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study

  2017cites this paper
• Women's attitude towards routine human platelet antigen‐screening in pregnancy

  2017cites this paper
• IDENTIFYING PREGNANCIES AT RISK

  2017cites this paper
• Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities

  2017influential citation
• A man‐made disease: Fetal neonatal alloimmune thrombocytopenia due to incompatibility between oocyte donor and gestational mother

  2017cites this paper
• Practice Bulletin No. 166: Thrombocytopenia in Pregnancy.

  2016cites this paper
• 52. Fetal and neonatal alloimmune thrombocytopenia

  2016cites this paper
• 20 Aan de zwangerschap gebonden afwijkingen

  2016cites this paper
• Factors contributing to the pathogenesis of IgG‐mediated alloimmune disease

  2016cites this paper
• Fetal and Neonatal Alloimmune Thrombocytopenia: Management and Outcome of a Large International Retrospective Cohort

  2016cites this paper
• Sensitive detection of platelet-specific antibodies with a modified MAIPA using biotinylated antibodies and streptavidin-coated beads.

  2016cites this paper
• Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia

  2016cites this paper
• Glycosylation pattern of anti‐platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia

  2016cites this paper
• Association between Fetal Cerebral Ventriculomegaly and Platelet Alloimmunisation

  2016cites this paper
• The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases

  2016cites this paper
• Severe bleeding complications other than intracranial hemorrhage in neonatal alloimmune thrombocytopenia: a case series and review of the literature

  2016cites this paper
• Maternal anti-HLA class I antibodies are associated with reduced birth weight in thrombocytopenic neonates.

  2016cites this paper
• Identification of anti-HPA-1a allo-antibodies using IgG platelet antibody detection and crossmatch system assay with Galileo Echo

  2015cites this paper
• Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention

  2015cites this paper
• Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial

  2015cites this paper
• Noninvasive fetal genotyping of human platelet antigen‐1a using targeted massively parallel sequencing

  2015cites this paper
• Anti-human platelet antigen (HPA)-1a antibodies: For better or for worse

  2015cites this paper